Abstract
Smoking is one of the more important risk factors for cardiovascular disease and it has remained a cause of death worldwide. The anti-smoking drug is the main toll of treatment antitabagism. In recent decades, these drugs were largely responsible for reductions in the prevalence of smokers. Some pharmacogenetic tests are now available to healthcare professionals and patients, and increasi…